Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Helminth therapy and multiple sclerosis.
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).
Response to "Glucocorticoids for treating Takotsubo syndrome?" and "Atypical global Takotsubo syndrome in a patient with acute disseminated encephalomyelitis".
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Pharmacokinetic profile of dalfampridine extended release: clinical relevance in patients with MS.
MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8(+) T cells.
Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis.
Multiple sclerosis and breast cancer.
Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine.
Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study.
Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients.
Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes.
CLARITY – Safety and Efficacy of Oral Cladribine in Subjects with Relapsing-remitting Multiple Sclerosis (MS)
Fingolimod-A sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes.
In vitro modeling of central nervous system myelination and remyelination.
Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial.
Ceramide Synthase 6 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis.
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.
Design and screening of a glial cell-specific, cell penetrating Peptide for therapeutic applications in multiple sclerosis.
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
Celiac disease and multiple sclerosis in the northwest of Iran.
Tysabri prescribing information
Autoimmune myelopathies.
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.

Pages